MedCrypt Inc., a provider of proactive security solutions for the healthcare space, announces that Liberate Medical has chosen MedCrypt’s API to help secure Liberate’s VentFree Respiratory Muscle Stimulator, a medical device which may reduce the number of days adult patients require mechanical ventilation, including patients with COVID-19. Liberate Medical received an Emergency Use Authorization (EUA) from the U.S. FDA for its VentFree Respiratory Muscle Stimulator on May 4, allowing for an early launch into the market.
“The demand for lifesaving medical devices is unlike anything the healthcare industry has experienced before,” says Mike Kijewski, MedCrypt CEO. “We are proud to be part of a solution that will directly help patients more quickly recover from complications due to COVID-19. MedCrypt looks forward to building on this new relationship to bring robust cybersecurity solutions to future generations of Liberate Medical products.”
The stimulator is intended to reduce disuse atrophy of the abdominal wall muscles caused by prolonged use of mechanical ventilation. Reducing the time patients spend on mechanical ventilation may help decrease the risks of prolonged hospital-acquired infections, deteriorated quality of life, and end of life. Fewer days spent on ventilation may also increase the availability of ventilators during the COVID-19 pandemic. With the early launch to market, MedCrypt will help Liberate integrate a solution that will facilitate secure firmware updates in the devices that will deploy around the U.S. and Europe.
“We are excited to be working with MedCrypt. With a single command, their API solution will make it simple and efficient to ensure that our VentFree devices are operating with secure firmware, allowing us to focus our efforts on assisting in the treatment of patients during the COVID-19 pandemic,” says Guillermo Cohen Freue, vice president of engineering at Liberate Medical. “The FDA Emergency Use Authorization was a huge step forward for our company and we are grateful for MedCrypt’s dedication in helping us fast-track these security solutions.”
Liberate Medical is working with healthcare institutions around the U.S. to get VentFree devices installed later this year.
MedCrypt offers proactive cybersecurity solutions for medical device manufacturers to build safe and secure medical devices by design. The company recently announced its acquisition of MedISAO, a cybersecurity information-sharing organization, in an effort to help MedCrypt customers to proactively address both FDA premarket and postmarket cybersecurity guidance.
